Company profile
ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on August 8, 2022 and the most recent on January 24, 2025 (ClearPoint System (Software Version 3.0)). Its most common review panel is Neurology (2 devices).
3AI devices
2022First decision
2025Latest decision
2Specialties
Per year
202220232025
By specialty
Related guides
Timeline
- ClearPoint System (Software Version 3.0) · Neurology · HAW
- ClearPoint System (Software Version 2.2) · Neurology · HAW
- ClearPoint Maestro Brain Model · Radiology · QIH